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mAbstract
Background: Extracorporeal membrane oxygenation (ECMO) circuits have been shown
to sequester circulating blood compounds such as drugs based on their physicochemical
properties. This study aimed to describe the disposition of macro- and micronutrients in
simulated ECMO circuits.
Methods: Following baseline sampling, known quantities of macro- and micronutrients
were injected post oxygenator into ex vivo ECMO circuits primed with the fresh human
whole blood and maintained under standard physiologic conditions. Serial blood
samples were then obtained at 1, 30 and 60 min and at 6, 12 and 24 h after the
addition of nutrients, to measure the concentrations of study compounds using
validated assays.
Results: Twenty-one samples were tested for thirty-one nutrient compounds. There
were significant reductions (p < 0.05) in circuit concentrations of some amino acids
[alanine (10%), arginine (95%), cysteine (14%), glutamine (25%) and isoleucine (7%)],
vitamins [A (42%) and E (6%)] and glucose (42%) over 24 h. Significant increases in
circuit concentrations (p < 0.05) were observed over time for many amino acids, zinc
and vitamin C. There were no significant reductions in total proteins, triglycerides, total
cholesterol, selenium, copper, manganese and vitamin D concentrations within the
ECMO circuit over a 24-h period. No clear correlation could be established between
physicochemical properties and circuit behaviour of tested nutrients.
Conclusions: Significant alterations in macro- and micronutrient concentrations were
observed in this single-dose ex vivo circuit study. Most significantly, there is potential for
circuit loss of essential amino acid isoleucine and lipid soluble vitamins (A and E) in the
ECMO circuit, and the mechanisms for this need further exploration. While the reductions
in glucose concentrations and an increase in other macro- and micronutrient
concentrations probably reflect cellular metabolism and breakdown, the decrement
in arginine and glutamine concentrations may be attributed to their enzymatic
conversion to ornithine and glutamate, respectively. While the results are generally
reassuring from a macronutrient perspective, prospective studies in clinical subjects
are indicated to further evaluate the influence of ECMO circuit on micronutrient
concentrations and clinical outcomes.
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Extracorporeal membrane oxygenation (ECMO) is increasingly being utilized as a vi-
able supportive treatment modality for acute severe refractory cardiorespiratory failure
[1-3]. It can be used short term where recovery of the lungs or heart is anticipated, or
as a bridge to long-term mechanical cardiac support or lung transplantation. Patients
supported on ECMO are not only critically unwell but are often at cross roads while
they await organ recovery or further definitive therapy [1]. Despite controversies [4]
around what constitutes optimal nutritional support in an intensive care unit (ICU),
preserving nutritional status and overall physical condition is an important aspect of
their management [5].
There is growing evidence that malnutrition in the critically ill influences morbidity
and mortality [6-8]. Patients may receive ECMO support for weeks or may have had
chronic disease which impacts their nutritional status pre-morbidly. Available data indi-
cates that feed intolerance may occur in up to 38% of the ECMO patients [5] and that
patients may be receiving as little as 50% of their nutritional requirements due to en-
teral feed intolerance [9] resulting in large caloric deficit. In this setting, sequestration
if any of vital nutrients in ECMO circuits may lead to further nutritional debilitation.
The ECMO circuit is not, however, a passive conduit for the blood and may sequester
a variety of circulating compounds such as drugs [10-12] and possibly nutrients, effect-
ively reducing the bioavailability of these compounds. Other ex vivo studies in cardio-
pulmonary bypass circuits have demonstrated that these circuits can sequester trace
elements [13]. Hence, it is therefore plausible that there may be clinically relevant inter-
actions between the ECMO circuit and macro-/micronutrients. However, to date, there
is no data pertaining to nutrient disposition in the ECMO circuit.
The aim of this 24-h single-dose study was to identify any significant reduction in
circulating concentrations of macronutrients (glucose, amino acids and fatty acids) or
micronutrients (fat soluble vitamins, water soluble vitamins, selenium, copper, zinc and
manganese) in an ex vivo ECMO circuit model primed with the fresh human whole
blood.Methods
Ethics approval was obtained from the local Human Research Ethics Committee
(HREC/12/QPCH/90).ECMO circuits
The methods for the development of the ex vivo model of ECMO used in the experi-
ment have been published previously [14]. Briefly, three new ECMO circuits were used
(Maquet Cardiopulmonary AG, Hechinger Strabe, Germany). Each circuit had an iden-
tical composition: Bioline tubing, a PLS Quadrox D oxygenator and a Rotaflow pump
head. A reservoir bladder (R-38; Medtronic Pty Ltd., Minneapolis, MN, USA) was
added to contribute compliance to the system and thus, allow blood sampling from a
closed circuit. The three circuits were initially primed with 0.9% saline (Baxter
Healthcare, Toongabbie, NSW, Australia). Five thousand international units of Porcine
mucous heparin (Pfizer Pty Ltd., Perth, Australia) was added to the circuits. The
fresh human whole blood (6 days old) was then added to the circuit in exchange
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sures of 230 to 250 mmHg.
The final volume of the pressurized circuit was 819 ± 82 mL with a mean haemoglo-
bin value of 70 ± 2 g/L. Oxygen tension in the circuit blood was maintained between
150 to 200 mmHg (mean 175 ± 8 mmHg). Circuit temperature was maintained at
37°C. The pH of the circulating blood was maintained in the range of 7.25 to 7.55 by
use of carbon dioxide gas or sodium bicarbonate solution added to the circuit. The pH,
pO2, pCO2, potassium and lactate were checked at baseline, 6 h and at the conclusion
of the experiment (24 h) to ensure consistency between all three circuits. Flow rates in
each circuit were maintained at 4 to 5 L/min. Ambient temperature and light condi-
tions were identical for all three circuits during the experiment.Preparation and injection of nutrient solutions
Standard parenteral nutrition (PN) solution was prepared from a ready-to-mix triple
phase bag containing amino acids, glucose, lipids and electrolytes (4QH.01TC, Baxter
Healthcare, Toongabbie, NSW, Australia) as per manufacturer's recommendations.
One dose each of trace element solution (10 mL Baxter MTEFE) and vitamin powder
(Baxter Cernevit reconstituted in 5 mL water) was added to the PN bag through a ster-
ile port. Each PN bag was agitated for 3 min to ensure thorough distribution of con-
tents while being covered by a light impermeable bag provided by the manufacturer.
After reconstitution, 10 mL of this solution was extracted in a clean 10-mL syringe and
then injected into the ex vivo circuit at the post-oxygenator site. This dose was selected to
emulate typical concentrations observed in an ECMO patient receiving total PN (70 mL/h
of 3:1 TPN premix solution) over a 24-h period. This was necessary to exclude any
concentration-dependent sequestration.Blood sample collection and nutrient assays
A 3-min period of equilibration was allowed for each circuit at a flow rate of 4 L/min
prior to injection of PN solution. Blood samples (10 mL each) were collected from each
circuit from the post-oxygenator site at time-points: baseline (after equilibration), 1
min (after addition of PN), 30 and 60 min and 6, 12 and 24 h. Figure 1 details the
collection of samples using light protective precautions to prevent photodegradation.
Samples were analysed using nutrient assays as outlined in Table 1.Statistical analysis
We used a mixed model with a random intercept for each circuit to control for the
nonindependence of results from the same circuit. The nutrient concentrations in sam-
ples drawn at 1-min interval following the injection of PN solution into the circuit were
included in the model as a baseline. The key predictor variable was time in hours which
we assumed to be linear. All analyses were made using R version 3.0.2. This model
accounts for the repeated responses from the same circuit using a random intercept.
The concentration of nutrient versus time curves (mean ± SEM) were plotted using
GraphPad Prism Version 5.03.
Key
ZN – Zinc VIT C – Vitamin C
SE – Selenium HAPTO – Haptoglobin
CUCERU – Copper and Ceruloplasmin TRIG – Triglycerides
MNB – Manganese CHOL – Total Cholesterol
AAP – Amino Acid Profile PROT – Total Protein
VIT A – Vitamin A GLU – Dextrose (total D-Glucose)
VIT E – Vitamin E EDTA – Ethylenediaminetetraaceticacid (anticoagulant)
VIT D – Vitamin D SST – Serum Separator Tube
Figure 1 Sample collection schedule.
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There were no circuit complications. There were no significant differences between
oxygen or carbon dioxide tensions, pH, temperature, electrolyte composition and
degree of hemolysis between circuits. Circuit parameters are described in Table 2.
Twenty-one samples were analysed for thirty-one nutrient compounds. Linear
changes in hourly nutrient concentrations in the ECMO circuit are presented in
Table 3. The 95% CIs for mean hourly changes for a majority of nutrients indicate
minimal variability in nutrient concentrations between circuits. Concentration versus
time curves for the test compounds are graphed in Figures 2,3,4. There were signifi-
cant reductions (p < 0.05) in circuit concentrations of some amino acids [alanine
(10%), arginine (95%), cysteine (14%), glutamine (25%) and isoleucine (7%)], vitamins
[A (42%) and E (6%)] and glucose (42%) over 24 h. Significant increases in circuit
concentrations (p < 0.05) were observed over time for most amino acids, zinc and
vitamin C. There were no statistically significant reductions in total proteins, triglyc-
erides, total cholesterol, selenium, copper, manganese and vitamin D concentrations
within the ECMO circuit over a 24-h period. While the reductions in glucose
concentrations and an increase in other macro- and micronutrient concentrations
probably reflect cellular metabolism and breakdown, the decrement in arginine and
glutamine concentrations may be attributed to their enzymatic conversion to
ornithine and glutamate, respectively. There was no significant correlation between
physicochemical properties such as molecular weight, polarity and solubility on
circuit disposition.
Table 2 Circuit parameters
Circuit 1 2 3
Total circuit volume (mL) 857 738 861
Crystalloid volume (mL) 325 203 374
Whole blood volume (mL) 532 535 487
Age of whole blood (days) 6 6 5
Temperature (C) 36.5 36.7 36.6
Heparin dose (IU) 5,000 5,000 5,000
Calcium chloride dose (mL) 10 10 10
Calcium dose (mmol) 3.4 3.4 3.4
Oxygen (L/min) 6 6 6
Table 1 Nutrient assay methods
Analyte Methodology
Zinc (serum) The Wako Zinc (Zn) test WAKO Germany
Selenium Atomic absorption spectrometry
Varian Model 280Z Zeeman GFAAS
Manganese (whole blood Mn) Atomic absorption spectrometry
Varian Model 280Z Zeeman GFAAS
Copper Atomic absorption spectrometry
Varian Model 280Z Zeeman GFAAS
Vitamin E (α-tocopherol) Reversed-phase HPLC with multiwavelength detection
Waters™ 2690/5 HPLC Alliance Separations System
Vitamin A (retinol and retinol esters) Reversed-phase HPLC with multiwavelength detection
Waters™ 2690/5 HPLC Alliance Separations System
Plasma amino acids Reverse phase UPLC and TUV detector
MassTrak™ Amino Acid Analysis Kit
Waters™ Acquity Ultra Performance LC System
Vitamin C (ascorbic acid) Spectrophotometric endpoint assay
Horiba ABX Diagnostics Pentra 400
Vitamin D (25-OH vitamin D2 and D3) Liquid chromatography-tandem mass spectrometry
TECAN EVO2. Waters™ Acquity Ultra Performance LC system
Haptoglobin Turbidimetric method
Beckman Coulter Synchron Clinical System
Triglycerides Timed-endpoint method
Beckman Coulter Synchron Clinical System
Cholesterol Timed-endpoint method
Beckman Coulter Synchron Clinical System
Protein (total protein) Timed-endpoint biuret method
Beckman Coulter Synchron Clinical System
Glucose (serum glucose) Glucose oxidase method
Beckman Coulter Synchron Clinical System
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Table 3 Linear changes over time in nutrient levels
Nutrient Units Mean Lower Upper p value
Macronutrients
Glucose* mmol/L −0.44 −0.47 −0.41 <0.001
Total protein g/L −0.02 −0.08 0.04 0.54
Total cholesterol mmol/L 0.00 −0.00 0.00 0.60
Triglycerides mmol/L −0.00 −0.02 0.00 0.45
Alanine* μmol/L −4.87 −7.78 −1.95 0.008
Arginine* μmol/L −19.6 −25.4 −13.83 <0.001
Citrulline μmol/L 0.10 0.04 0.15 <0.003
Cystine* μmol/L −0.07 −0.16 0.01 0.12
Glutamate μmol/L 3.86 3.23 4.48 <0.001
Glutamine* μmol/L −2.34 −3.29 −1.38 <0.001
Glycine μmol/L −0.04 −3.23 3.14 0.97
Histidine μmol/L 1.14 0.78 1.51 <0.001
Isoleucine* μmol/L −0.61 −1.08 −0.13 0.02
Leucine μmol/L 2.43 1.69 3.17 <0.001
Lysine μmol/L 0.8 0.34 1.410 0.006
Ornithine μmol/L 20.64 15.42 25.85 <0.001
Phenylalanine μmol/L 1.04 0.57 1.51 0.001
Proline μmol/L 0.24 −0.60 1.08 0.57
Serine μmol/L 0.32 −0.20 0.83 0.23
Taurine μmol/L 0.90 0.43 1.37 0.002
Threonine μmol/L 0.83 0.35 1.31 0.007
Tyrosine μmol/L 0.62 0.46 0.77 <0.001
Valine μmol/L 1.86 1.01 2.71 <0.001
Trace elements
Copper μmol/L −0.00 −0.02 0.02 1
Manganese nmol/L −0.20 −0.51 0.1 0.23
Selenium μmol/L 0.00 −0.00 0.01 0.21
Zinc μmol/L 0.06 0.04 0.09 <0.001
Vitamins
Vit A* nmol/L −0.01 −0.01 −0.01 <0.001
Vit C nmol/L 1.53 1.01 2.06 <0.001
Vit D nmol/L −0.05 −0.22 0.13 0.62
Vit E* nmol/L −0.03 −0.04 −0.01 0.003
Using a mixed model with post-parenteral nutrition solution injection plasma nutrient concentrations as the baseline and
a random intercept for each circuit. Mean changes and 95% confidence intervals. The estimates in the table are per hour.
For example, for alanine, the mean loss in 4.87 units per hour with a 95% confidence interval of −7.78 to −1.95. Nutrients
with significant reductions in concentrations over 24 h are marked in asterisk (*).
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To our knowledge, this study represents the first investigation of macro- and micronu-
trient disposition in ex vivo ECMO circuits. Significant alterations in macro- and
micronutrient concentrations were observed in this study. Most significantly, there is
potential for circuit loss of essential amino acid isoleucine and lipid soluble vitamins
(A and E) in the ECMO circuit, and the mechanisms for this need further exploration.
While the results are generally reassuring from a macronutrient perspective,
Figure 2 Glucose, lipid and total protein concentrations in the ex vivo ECMO circuit over the 24-h
study period.
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of ECMO circuit on micronutrient concentrations and clinical outcomes.
The findings of this preliminary study that identifies nutrients that risk being lost in
ECMO circuits are significant for the following reasons. In the absence of circuit
sequestration of most macro- and micronutrients, it can be assumed that the nutrient
bioavailability from enteral feeds should be almost entirely related to feed tolerance and
absorption and clinicians can focus on improving either of these as feasible. Equally,
when feed intolerance is intractable, PN in standard doses may be a viable option. Most
importantly, identifying the macro- and micronutrients that are most affected by the
addition of an extracorporeal circuit to a critically ill patient may allow better nutri-
tional surveillance and/or supplementation as appropriate. While the tested nutrients
play an important role in health and disease, it is unlikely that the adverse clinical out-
comes if any of circuit nutrient loss and benefits if any of supplementing at risk nutri-
ents will ever be tested in a randomised trial design and is probably not of sufficient
priority. However, minimising the biological burden from mechanical assist device
therapy has the potential to improve patient outcomes, and this study is one step in
that direction.
Nutrient compounds possess unique physicochemical properties - size, charge and
hydrophobicity vary significantly within and between each nutrient group [15]. Glucose
is polar, ionic and hydrophilic; the amphipathic fatty acids possess both hydrophilic and
lipophilic properties; and amino acids can be measured on a hydrophobicity index due
to the varying solubilities of different amino acids in water and in varying pH condi-
tions [15-17]. The majority of vitamins are hydrophilic with the exception of vitamins
A, D, E and K, which are lipophilic; trace elements such as copper, manganese and zinc
are positively charged cations; and selenium is a negatively charged anion [15]. No clear
correlation could be established between physicochemical properties such as polarity,
solubility or molecular weight and circuit behaviour of nutrients.
In this setting, interpretation of the alterations in individual nutrient concentrations
is challenging as several physical, chemical, environmental and other unknown factors




Figure 3 Amino acid concentrations in the ex vivo ECMO circuit over the 24-h study period (a-c).
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Figure 4 Circulating trace element and vitamin concentrations in the ex vivo ECMO circuit over the
24-h study period.
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[18-21]. Similarly, the decrease in glucose concentrations over time may be explained
in part by cellular metabolism. The reductions in concentrations of amino acids such
as cysteine, isoleucine and alanine and vitamins (A and E) may be explained by instabil-
ity, degradation, circuit sequestration or oxidative mechanisms [22]. It is possible that
lipophilicity of vitamins A and E may affect their circuit disposition; however, this was
not a consistent trend as another lipophilic vitamin D was relatively unaffected. We
also hypothesise that an increase in concentrations of many other nutrients in a closed
circuit probably represents breakdown of cellular and noncellular components of the
whole blood and detailed evaluation of mechanisms responsible for alterations in
individual nutrient concentrations is beyond the scope of this experiment.
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the ECMO circuit and the clinical relevance of this remains unclear. While saturation
of circuit binding sites over time may partly alleviate circuit loss of nutrients, the circuit
loss from other mechanisms such as chemical and physical degradations, oxidation etc.
may continue over the duration of ECMO, as up to second/third of patient's cardiac
output may be exteriorised every minute for gas exchange and mechanical circulatory
support [23]. Even though enteral or parenteral nutritional support and endogenous
synthetic/metabolic mechanisms ensure an ongoing supply of macro- and micronutri-
ents into the blood stream during ECMO, its unclear how much of their bioavailability
is affected by ongoing losses in the circuit. In addition, the circuit loss of some nutri-
ents can further be compounded by critical illness factors [24-26] such as inflamma-
tion, multiple organ dysfunction, fluid shifts and capillary leaks that may further affect
their bioavailability. Interestingly, this may be the fate of many circulating endogenous
compounds such as hormones and many other biologically active substances which are
neither monitored nor replaced during ECMO. This calls for further clinical studies to
further elucidate the biological impact of the ECMO circuit on circulating nutrients.
This study has limitations. We attempted to replicate the clinical scenario ex vivo,
which allowed us to specifically study the interactions between the nutrients and the
ECMO circuit under physiologic conditions in the absence of patient and pathological
factors. This single-dose study, however, contrasts with the clinical scenario wherein
there is ongoing delivery of nutrients into the blood stream and ECMO support may
be continued for days to weeks. A continuous infusion of PN solution into the fully
primed, noncompliant circuit was not feasible. Although a reservoir bladder which is
seldom used in adult patients may have added compliance to the circuit, it could have
further confounded our results by sequestering test compounds or creating areas of sta-
sis, both of which are undesirable. The absence of circulating drugs, other blood com-
ponents and metabolites in our experiment may also influence nutrient interactions
with the components of the circuit. We did not test nutrient losses in physiologic
controls (fresh human whole spiked with equivalent dose of PN solution, stored at
37°C over 24 h) to measure nutrient losses if any over time, independent of the ECMO
circuit which to an extent limited the interpretation of our results.
However, this study delineates the circuit behaviour of thirty-one vital nutrients and
serves as a necessary first step in identifying at risk nutrients and identifies areas for
further research.Conclusions
Except for essential amino acid isoleucine and vitamins (A and E), most other macro-
and micronutrients tested in this study were stable in the ECMO circuit over 24 h.
Exteriorisation of large amounts of patient blood volume for ECMO is life-saving but
may lead to circuit loss of vital nutrients. Critical illness may further exacerbate these
circuit interactions of nutrients, and future studies should further evaluate altered
nutrient disposition during ECMO and their potential impact on clinical outcomes.Abbreviations
ECMO: extracorporeal membrane oxygenation; EN: enteral nutrition; MTEFE: micronutrient and trace elements with
iron; PN: parenteral nutrition; SEM: standard error of the mean; TPN: total parenteral nutrition.
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